DUBLIN, Dec. 30, 2025 (GLOBE NEWSWIRE) — “AI-Based Digital Pathology Market: Industry Trends and Global Forecast to 2035 – Neural Network Types, Assay Types, End User Types, Application Fields, Target Disease Indications and Distribution by Key Regions” has been added. ResearchAndMarkets.com Offerings.
The global AI-based digital pathology market is projected to grow from USD 1.01 billion this year to USD 2.32 billion by 2035, reflecting a CAGR of 8.7%. This growth is being driven by technological advances and an emphasis on precision medicine, powered by digital pathology techniques that enable more efficient quantitative and qualitative assessments.
Market dynamics and opportunities
The introduction of AI in digital pathology has revolutionized slide examination, replacing traditional microscopy. Digitization of glass slides facilitates rapid transfer from the diagnostic center to the pathologist and greatly improves understanding of the tissue microenvironment. The integration of AI in diagnostics enables customized treatment strategies and patient classification, facilitating innovative care delivery models across pathology subdomains.
market insights
Currently, around 80 companies around the world provide AI-based digital pathology services, primarily to research institutions and diagnostic facilities. Companies offer a variety of AI-based solutions powered by proprietary products primarily used for research and diagnostics.
The market has attracted significant investment, with approximately US$2 billion invested across 60 fundraising events. Factors such as the integration of AI into clinical workflows and increasing adoption of these tools globally are driving market growth, which is expected to maintain an annual growth rate of 8.70% through 2035.
Key insights:
- The demand for AI-based digital pathology solutions is increasing, and convolutional neural networks are leading the market due to their wide range of applications. Ki67 assays dominate the market due to their high relevance to cell proliferation.
- Currently, research institutions account for the largest market share, and diagnostic applications are projected to show higher growth rate. Breast cancer is the main disease indication and accounts for the largest market share.
- Geographically, North America accounts for the largest market share, while the European market is expected to grow at a higher CAGR.
Players to watch:
- iforia technologies
- Akoya Bioscience
- Ibex Medical Analytics
- Indica Research Institute
- page
- path AI
- prussia
- roche tissue diagnosis
- Vizio Farm
Research and analysis
The report includes extensive market sizing and opportunity analysis, segmentation by neural network types, assays, end users, and target disease indications. We also provide a thorough company landscape assessment and competitive analysis, focusing on market leaders and emerging companies.
Reasons to buy:
- Comprehensive market analysis with detailed revenue forecasts and competitive dynamics insights for strategic decision making.
- Access key market trends and growth prospects to help stakeholders take advantage of new opportunities.
Additional benefits:
- Free PPT Insights Pack and Excel Data Pack
- Free content customization and report updates
- In-depth walkthrough session with the research team
key attributes
| report attributes | detail |
| Number of pages | 212 |
| Forecast period | 2025-2035 |
| Estimated market value in 2025 (USD) | 1.01 billion dollars |
| Projected market value to 2035 (USD) | $2.32 billion |
| compound annual growth rate | 8.7% |
| Target area | global |
Covers key topics
1. Introduction
- 1.1.Chapter overview
- 1.2.Market Segmentation
- 1.3. Research method
- 1.4.Answers to key questions
- 1.5.Chapter overview
2. Executive summary
3. Introduction
- 3.1.Chapter overview
- 3.2.Artificial intelligence in digital pathology
- 3.3. AI-based digital pathology workflow
- 3.4. Applications of AI-based digital pathology solutions
- 3.5. Regulatory requirements focused on AI-based digital pathology
- 3.6. Challenges associated with using AI in digital pathology
- 3.7. Future prospects
4. AI-based Digital Pathology: Market Status
- 4.1.Chapter overview
- 4.2. AI-based digital pathology providers: the developer landscape
- 4.3. AI-based Digital Pathology Providers: Market Status
5. AI-based Digital Pathology Market: Key Insights
6. Company profile
- 6.1.Chapter overview
- 6.2.Path AI
- 6.3. Paige
- 6.4.Akoya Bioscience
- 6.5. Prussia
- 6.6.Visiofarm
- 6.7.Roche Tissue Diagnosis
- 6.8. iforia Technologies
- 6.9. Indica Research Institute
- 6.10.Ibex Medical Analytics
7. Corporate competitiveness analysis
- 7.1.Chapter overview
- 7.2. Assumptions and key parameters
- 7.3. Methodology
8. Financing and investment
- 8.1.Chapter overview
- 8.2. Types of funds
9. Demand analysis
- 9.1.Chapter overview
- 9.2. Scope and methodology
10. Market size and opportunity analysis
- 10.1.Chapter overview
- 10.2. Forecasting methods and key assumptions
11. Conclusion
12. Management Insights
13. Appendix 1: Tabular data
14. Appendix II: List of Companies and Organizations
Companies mentioned in this report include, but are not limited to:
- 3D histech
- 50 partners
- 83 north
- 8VC
- ACME Investments
- Act Venture Capital
- proverb
- ether AI
- Agilent Technologies
- Aiforia
- Akoya Bioscience
- actia nordic micro cap
- alpha intelligence capital
- Alverno Institute
- moon
- anapas
- angels sante
- APEX Ventures
- Ascend Capital Partners
- ATP
- Augmentics
- Augsburg University Hospital
- Aventiol
- Axon diagnosis
- bank investment
- bavarian capital
- BGV
- Biospring Partners
- bioview
- blue venture fund
- breyer capital
- bristol myers squib
- CL Davids Fond
- Cades
- Kasdin Capital
- Catario Capital Management
- Sercarta
- Charles River Institute
- cleveland clinic
- Corista
- cross scope
- Clinicec Institute
- D1 Capital Partners
- Danhua Capital
- data brick
- data band
- Decifex
- Dedalus
- deep bio
- Deepathology.ai
- Dell
- DHVC
- diagnesia
- Digital Pathology Lab
- Dr. Lal Pathlab
- emerald development manager
- enterprise ireland
- entrepreneur investor
- EOSIN Microscope Intelligence
- Epredia
- fairhaven capital
- FFEI
- Flagship bioscience
- fluid mechanics
- Flybridge Capital Partners
- Fonds Ambition Amorcage Angels
- fusion fund
- general atlantic
- common catalyst
- Junuf
- gestalt diagnosis
- GI partner
- glaxosmithkline
- glencoe software
- GNI Group
- Godman Sachs Merchant Banking Division
- gray slide imaging
- Halo Business Angel Network
- Hamamatsu Photonics
- HBAN Medtech Syndicate
- healthcare venture
- Health Quest Capital
- Highline Capital Management
- high tech grander fonds
- histo index
- Hitachi Ventures
- Hologic
- hospitex international
- Huron Digital Pathology
- Ibex Medical Analytics
- Imma Biotech
- insight
- Indica Research Institute
- eye care
- Infinite
- Notify diagnosis
- Innovation Starter Fonds Hamburg
- Innovatus Capital Partners
- Inovata Personalized Health Accelerator
- Inspirata
- intel
- inviclo
- Erath Investments
- janssen
- jinan danger electronic
- JLK
- Johnson & Johnson Innovation
- kaiser permanente
- Kamet Ventures
- KdT Ventures
- Kenan Turnasioglu
- KFBIO
- KKR
- labcorp
- leica biosystems
- Lumea
- Lunafore
- mayo clinic
- Mechano Mind
- Merck
- micro dimension
- mind peak
- Motic Digital Pathology
- Motu Ventures
- nantes omics
- National Cancer Institute
- National Science Foundation
- NextStep Ventures NGD-Lab
- nina capital
- northcap university
- Novartis
- Octopus Ventures
- one cell
- Ontario Centers of Excellence
- Optatec
- optra scan
- oracle bio
- orange digital ventures
- Innovation at Oxford University
- page
- parapixel
- Parkwalk Advisor
- Partek
- path AI
- pattern
- pass score
- Pele Doctor
- outlook
- PHC
- philips
- pictor lab
- Pillar VC
- Piper Jaffrey Merchant Banking
- Plan Ben Entrepreneurial Ventures
- plug and play
- Polaris Partners
- poplar healthcare
- PP Capital
- Pramana
- Primer
- prussia
- Puhoa capital
- quest diagnosis
- Razor's Edge Ventures
- refactor capital
- Revealing bioscience
- robin hood ventures
- robo global
- roche tissue diagnosis
- RT Capital Management
- Sana Kliniken Berlin Brandenburg
- scale venture partner
- Sectra
- sentient med
- siemens healthneers
- sig tuple
- smart in media
- Sonora Quest Laboratories
- STO-Lahoitus
- SV market
- Targos
- tech site
- Telegraph Hill Partners
- tiger global management
- Triangle Peak Partners
- Tribune Health
- US Department of Energy
- Ultiview
- Unilab
- UNIM
- University of Edinburgh
- Oxford University School of Health
- US Department of Energy
- Waxtvonden
- Vichy
- Vizio Farm
- western digital capital
- WSK Medical
- XIFIN
- Xayai
- Zegami
For more information on this report, please visit https://www.researchandmarkets.com/r/izzn6r.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
-
AI-based digital pathology market
